Washington, D.C. -Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement regarding the White House Office of National Drug Control Policy’s 2022 National Drug Control Strategy :
“The 2022 National Drug Control Strategy reflects the Biden-Harris Administration’s deep commitment to overcoming our nation’s overdose crisis and ensuring that every person who experiences addiction can achieve and sustain recovery.
I applaud the Office of National Drug Control Policy for its work to expand access to high-quality treatment and harm reduction services, disrupt the flow of dangerous substances into the United States, and advance equity in the federal government’s response to overdose and addiction. I look forward to hearing directly from Director Gupta about the National Drug Control Strategy and the Administration’s progress in overcoming this public health crisis."
